Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas
University of Chicago
University of Chicago
BeOne Medicines
Dana-Farber Cancer Institute
Acerta Pharma BV
Incyte Corporation
AstraZeneca
Ohio State University Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Acerta Pharma BV
University of California, San Diego
M.D. Anderson Cancer Center
University of Utah
Mayo Clinic
MingSight Pharmaceuticals, Inc
Aprea Therapeutics
Genmab
Altor BioScience
M.D. Anderson Cancer Center
Sumitomo Pharma America, Inc.
OHSU Knight Cancer Institute
AbbVie
Asana BioSciences
Dana-Farber Cancer Institute
Atara Biotherapeutics
Precision BioSciences, Inc.
Molecular Templates, Inc.
Fred Hutchinson Cancer Center
Alexion Pharmaceuticals, Inc.
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Celgene
Aptevo Therapeutics
Novartis
Mayo Clinic
Mayo Clinic
Mayo Clinic
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Innate Pharma
OHSU Knight Cancer Institute
Mayo Clinic
University of California, San Diego
Alexion Pharmaceuticals, Inc.
Gruppo Italiano Malattie EMatologiche dell'Adulto
Gruppo Italiano Malattie EMatologiche dell'Adulto
Memorial Sloan Kettering Cancer Center
Gilead Sciences
National Cancer Institute (NCI)
Stanford University